Ulcerative Colitis: Vixarelimab Study

We are testing Vixarelimab to see if it is safe and effective for people with moderate to severe active ulcerative colitis. This study aims to improve treatment options for this condition.

1-2 yearsSafety phase (I)GastroenterologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Charite Research Organisation GmbH
Berlin, Germany
Sponsor: Genentech Inc.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.